News | RIVM

Nature Nanotechnology publishes RIVM research on plastics

On Thursday 20 January, Nature Nanotechnology published the article Quantitative tracing of uptake and transport of submicrometre plastics in crop plants using lanthanide chelates as a dual-functional tracer.

Microplastics in paint can cause problems in the environment

Companies and organisations in the paint sector are aware that microplastics can cause problems as these particles end up in the environment where they persist and may be harmful to plants and anim

More reports of adverse effects of implants in 2019

In 2019, the Dutch reporting centre for adverse effects of medical implants (MEBI) received 397 reports of suspected adverse effects. The reports concerned 462 implants.

Mesh implants intended to treat pelvic organ prolapse

Synthetic mesh are used to treat patients with pelvic organ prolapse.

State Secretary Blokhuis: boys will also be vaccinated against HPV virus

The vaccine against the HPV human papillomavirus virus will also become available for boys.

Measures against polluting microplastics from garments

When garments made from synthetic materials wear, due to use and washing, microplastic fibres are released. Wastewater treatment plants remove 50 to 90 per cent of these microplastic fibres.

Animatie waarin je persoon ziet lopen op gras, met daaronder de bodem met daaronder waterlaag met zwemmende vissen

Summary International Expert Meeting on breast implant-associated lymphoma

On November 19th 2018, RIVM organised an international expert meeting on a rare type of lymphoma that is associated with breast implants.

Sustainability Day at RIVM: Microplastics

Today, 10 October 2018, is national Sustainability Day in the Netherlands.

Research: HPV vaccine is safe

RIVM research shows no causal link between the vaccine against cervical cancer (HPV) and long-term fatigue symptoms in girls.

Vaccination rate again drops slightly, HPV vaccination rate drops considerably

The vaccination rate for vaccines included in the National Immunisation Programme has dropped slightly by about 1 percent.